NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) EBITDA (2019 - 2025)

Updated

NovaBridge Biosciences (NBP) recorded EBITDA of -$72.68 million in Q4 2025, compared with -$13.16 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) EBITDA (2019 - 2025) Analysis & Trends

For FY2025, NovaBridge Biosciences reported EBITDA of -$93.41 million.

  • Across earlier years, EBITDA came in at -$50.41 million in FY2024, -$70.82 million in FY2023, -$51.56 million in FY2022 and -$318.86 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 8.16 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.05 Bn
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -72.68 Mn
Sep 30, 2025 -8.77 Mn
Dec 31, 2024 -13.16 Mn
Sep 30, 2024 -12.22 Mn
Dec 31, 2020 140.07 Mn
Sep 30, 2020 -56.77 Mn
Dec 31, 2019 -46.94 Mn
API Access

NovaBridge Biosciences EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=NBP&period=max&api_key=YOUR_API_KEY